↓ Skip to main content

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort

Overview of attention for article published in BMC Cancer, January 2009
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
46 Mendeley
citeulike
1 CiteULike
Title
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort
Published in
BMC Cancer, January 2009
DOI 10.1186/1471-2407-9-43
Pubmed ID
Authors

Christopher A Haiman, Rachel R Garcia, Chris Hsu, Lucy Xia, Helen Ha, Xin Sheng, Loic Le Marchand, Laurence N Kolonel, Brian E Henderson, Michael R Stallcup, Geoffrey L Greene, Michael F Press

Abstract

Only a limited number of studies have performed comprehensive investigations of coding variation in relation to breast cancer risk. Given the established role of estrogens in breast cancer, we hypothesized that coding variation in steroid receptor coactivator and corepressor genes may alter inter-individual response to estrogen and serve as markers of breast cancer risk.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 17%
Researcher 7 15%
Professor > Associate Professor 5 11%
Student > Master 4 9%
Professor 3 7%
Other 12 26%
Unknown 7 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 39%
Medicine and Dentistry 9 20%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 2 4%
Social Sciences 2 4%
Other 3 7%
Unknown 9 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2021.
All research outputs
#7,454,951
of 22,790,780 outputs
Outputs from BMC Cancer
#2,059
of 8,294 outputs
Outputs of similar age
#49,628
of 170,536 outputs
Outputs of similar age from BMC Cancer
#13
of 35 outputs
Altmetric has tracked 22,790,780 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,294 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,536 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.